188 related articles for article (PubMed ID: 31644317)
21. Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.
Guo H; Shenoy N; Gershman BM; Yang J; Sklar LA; Miao Y
Nucl Med Biol; 2009 Apr; 36(3):267-76. PubMed ID: 19324272
[TBL] [Abstract][Full Text] [Related]
22. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
Guo H; Miao Y
J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
[TBL] [Abstract][Full Text] [Related]
23. Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake.
Guo H; Yang J; Gallazzi F; Miao Y
J Nucl Med; 2010 Mar; 51(3):418-26. PubMed ID: 20150256
[TBL] [Abstract][Full Text] [Related]
24. Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model.
Miao Y; Hoffman TJ; Quinn TP
Nucl Med Biol; 2005 Jul; 32(5):485-93. PubMed ID: 15982579
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
[TBL] [Abstract][Full Text] [Related]
26. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
27. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
28. Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues.
Cheng Z; Chen J; Miao Y; Owen NK; Quinn TP; Jurisson SS
J Med Chem; 2002 Jul; 45(14):3048-56. PubMed ID: 12086490
[TBL] [Abstract][Full Text] [Related]
29. Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.
McQuade P; Miao Y; Yoo J; Quinn TP; Welch MJ; Lewis JS
J Med Chem; 2005 Apr; 48(8):2985-92. PubMed ID: 15828837
[TBL] [Abstract][Full Text] [Related]
30. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.
Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP
J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.
Yang J; Guo H; Gallazzi F; Berwick M; Padilla RS; Miao Y
Bioconjug Chem; 2009 Aug; 20(8):1634-42. PubMed ID: 19552406
[TBL] [Abstract][Full Text] [Related]
32. The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging.
Kobayashi M; Kato T; Washiyama K; Ihara M; Mizutani A; Nishi K; Flores LG; Nishii R; Kawai K
PLoS One; 2019; 14(3):e0213397. PubMed ID: 30901323
[TBL] [Abstract][Full Text] [Related]
33. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
[TBL] [Abstract][Full Text] [Related]
34. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
35. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
[TBL] [Abstract][Full Text] [Related]
36. Preclinical Melanoma Imaging with
Zhang C; Zhang Z; Lin KS; Pan J; Dude I; Hundal-Jabal N; Colpo N; Bénard F
Theranostics; 2017; 7(4):805-813. PubMed ID: 28382155
[TBL] [Abstract][Full Text] [Related]
37. Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues.
Miao Y; Fisher DR; Quinn TP
Nucl Med Biol; 2006 Aug; 33(6):723-33. PubMed ID: 16934691
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.
Chen J; Cheng Z; Owen NK; Hoffman TJ; Miao Y; Jurisson SS; Quinn TP
J Nucl Med; 2001 Dec; 42(12):1847-55. PubMed ID: 11752084
[TBL] [Abstract][Full Text] [Related]
39. Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.
Froidevaux S; Calame-Christe M; Tanner H; Eberle AN
J Nucl Med; 2005 May; 46(5):887-95. PubMed ID: 15872364
[TBL] [Abstract][Full Text] [Related]
40. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.
Miao Y; Benwell K; Quinn TP
J Nucl Med; 2007 Jan; 48(1):73-80. PubMed ID: 17204701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]